skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

99+ Total results for product and free and sample content found

Scrip

J.P. Morgan Conference Updates

By Mandy Jackson 17 Jan 2020

JP_Morgan_Notebook_Day_1

Updates and coverage of the 2020 J.P. Morgan Healthcare Conference in San Francisco.

HBW Insight

OTC Zantac And Private Label Ranitidine Numerous In FDA Recall Updates

15 Jan 2020

OTC_Zantac_And_Private_Label

In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in FDA's database updates through 9 January are Amneal Pharmaceuticals, Preferred Pharmaceuticals, which distributed products made by Amneal, and Granules India Ltd.

HBW Insight

Bayer Harnessing Skin Microbiome In New Product Development

By Tom Gallen 15 Jan 2020

Bayer_Harnessing_Skin_Microbiome

Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions. 

Pink Sheet

EU 2019 Approvals: Novel Therapies Make Strong Showing

By Ian Schofield 15 Jan 2020

EU_2019_Approvals_Novel_Therapies

Bluebird bio’s gene therapy Zynteglo, Akcea’s antisense drug Waylivra and BioMarin’s enzyme substitution therapy Palynziq were among the novel innovative medicines that were approved in Europe in 2019. 

HBW Insight

Steripod Bolt-on Deal Extends Perrigo Into Toothbrush And Razor Accessories

By Eileen Francis 08 Jan 2020

Steripod_Bolton_Deal_Extends

Perrigo's Ranir division purchased the brand, which includes a portfolio of antibacterial toothbrush protectors, children’s products and tongue cleaners, for an undisclosed amount from Bonfit America.

Medtech Insight

Execs On The Move: Two Top Appointments At RTI Surgical; A CEO Promotion At Guerbet

08 Jan 2020

Execs_On_The_Move_Two_Top_Appointments

RTI Surgical, a surgical implants company, hired a global spine president and an original equipment manufacturer products president; Guerbet, a maker of medical-imaging products, promoted its chief commercial officer to CEO; and more.

Medtech Insight

FDA Will Keep Listening To Patient-Engagement Experts

By Ferdous Al-Faruque 08 Jan 2020

FDA_Will_Keep_Listening

The US agency says in a 6 January Federal Register notice that it’s keeping its Patient Engagement Advisory Committee in place through October 2021 so it can gather more patient feedback that will come in handy when regulatory decisions need to be made. The committee, formed after the agency made a cultural shift to consider patient input on the types of products it allows on the market, was supposed to expire October 2019.

HBW Insight

'Supplement' on CBD Product Label A Bullseye For US Litigants, Says Attorney

By Eileen Francis 18 Dec 2019

Supplement_On_CBD_Product_Label_A_Bullseye_1

Two CBD marketers warned by FDA in a recent crackdown are targeted in class action complaints alleging they made unsubstantiated health claims and mislabeled ‘illegal drug’ products as supplements. Complaints are a wake-up call to CBD wellness industry to ensure claims are substantiated, as the class action bar is on the prowl following the agency’s 15 warning letter blast in November.

Generics Bulletin

Alberta Is Second Canadian Province To Switch To Biosimilars

By David Wallace 18 Dec 2019

Alberta_Is_Second_Canadian_Province_To_Switch_1

Alberta has become the second Canadian province to announce a biosimilar switching program, following the example set by British Columbia earlier this year. The move has been welcomed by Biosimilars Canada but criticized by originator-backed body Crohn’s and Colitis Canada.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: